Latest publications
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.
Journal article
Rampotas A. et al, (2026), Sci Transl Med, 18
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.
Journal article
Pemmaraju N. et al, (2026), Blood
ChatMDV: Reducing Technical Barriers in Bioinformatics Analysis using Large Language Models.
Journal article
Kiourlappou M. et al, (2026), Gigascience
Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.
Journal article
Munro J. et al, (2026), Sci Rep
Upcoming Seminars
Protein-protein interaction networks of leukemia
Tuesday, 01 September 2026, 1pm to 2pm
Speaker(s): Akhihiko Yokoyama
Series: Molecular Haematology Unit
Therapeutic targeting of epigenetic enzymes in haematological malignancies
Tuesday, 22 September 2026, 1pm to 2pm
Speaker(s): Professor Tim Somervaille
Series: Molecular Haematology Unit, WIMM
TBC
Tuesday, 06 October 2026, 1pm to 2pm
Speaker(s): Inigo Martincorena (Wellcome Sanger Institute)
Series: Molecular Haematology Seminar Series
WIMM Seminar - Malignant Transformation of the Immune System and Precision Therapy for Immune Neoplasms
Thursday, 15 October 2026, 12pm to 1pm
Speaker(s): Dr Ari Melnick (Josep Carreras Leukaemia Research Institute Barcelona)
Series: WIMM THURSDAY SEMINARS


